Less chemotherapy is as effective at controlling disease for elderly or frail patients with advanced cancer of the stomach or oesophagus (food pipe), and leads to fewer side effects such as diarrhoea and lethargy. These are the results of a Cancer Research UK funded study, presented prior to the ASCO conference today (Wednesday).
“Increasingly we’re realising it’s not just age that affects how well someone can tolerate their treatment and we need to do more work to understand how other conditions or aspects of frailty might play a role.” – Dr Peter Hall, Cancer Research UK Edinburgh Centre
Read more at: https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2019-05-15-less-chemotherapy-better-for-older-or-frail-patients-with-advanced-stomach-and-oesophageal-cancers
